GPNMB and early-onset autosomal dominant Alzheimer disease: GPNMB is a transmembrane glycoprotein implicated in a multitude of cellular processes including proliferation, cell adhesion and inflammation and has been reported to be increased in expression in several microglial reactive states including in Alzheimer’s disease[53, 54], Parkinson’s disease[55] and diabetic retinopathy[56].